Lower ARV prices negotiated in Mexico
This article was originally published in Scrip
Executive Summary
Several pharmaceutical companies have reduced the prices of their antiretrovirals in Mexico following negotiations with the government there, the Mexican health ministry has said. Thanks to the reductions, the ministry estimates that it will save Ps310 million ($30.6 million) annually.
You may also be interested in...
UK: Commercial Framework Sheds Light On Working With NHS And NICE
The final text brings some changes, including the introduction of an escalation process when companies and NHS England cannot agree.
Time Is Ripe For Global Action On Orphan Biosimilars
European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.
Time Is Ripe For Global Action On Orphan Biosimilars
European industry association wants global convergence on development requirements, though the European Medicines Agency says that this would prove challenging.
Need a specific report? 1000+ reports available
Buy Reports